Derycz Scientific, Inc. reported earnings results for the first quarter ended September 30, 2009. For the quarter, the company reported revenue of $4,783,699 compared to revenue of $3,202,726 for the three months ended September 30, 2008, or an increase of 49%. The revenue of Derycz's main operating company, Reprints, increased from $2,807,466 for the three months ended September 30, 2008 to $4,025,667 for the three months ended September 30, 2009, an increase of 43%. The company reported a net loss of $310,691 compared to a $232,666 net loss in the same period of 2008.

Derycz Scientific Inc. reported earnings results for the fourth quarter and full year ended June 30, 2009. For the quarter, the company reported increased revenues were $4,205,195. For the year, the company reported a net loss of $1,066,041 compared to a net loss of $338,321 for the year ended June 30, 2008. Over half of the reported losses were due to stock option grants and investor relations expenditures after the stock was listed on the Over-the Counter Bulletin Board. A greater than 20% increase in gross revenues to nearly $15,000,000 for Fiscal Year 2009, compared to nearly $12,000,000 for the prior fiscal year.

Derycz Scientific Inc. announced the availability of Reprints NRx for the Force.com AppExchange from salesforce.com. Built using the Force.com platform, Reprints NRx for the AppExchange is a procurement service that enables buyers in healthcare marketing and communications, sales, product management, and medical affairs, to request quotes and place orders for reprints of peer-reviewed articles from within Salesforce CRM. Buyers of article reprints use them in promotions and in educational programs. Salesforce CRM customers and prospects can deploy and test drive Reprints NRx for the Force.com AppExchange and also watch a video demonstration, download an informational datasheet, and view screenshots, specifications and other information. The Reprints NRx service for the Force.com AppExchange enables sales and marketing professionals in life sciences to order and to track the distribution of high-quality custom reproductions of these materials as a direct part of their workflow in the Force.com platform.